3D Epigenome Remodelling in Endocrine Resistant Breast Cancer

3D Epigenome Remodelling in Endocrine Resistant Breast Cancer

🎙 Joanna Achinger-Kawecka 👥 1K 📅 June 22, 2020 ⏱ 21 min 👁 136 📄 original study 🧭 2026-08-18
Available in: English (current) Français

Keywords

epigenomechromatinendocrine resistanceHi-CDNA methylation

Summary

Joanna Achinger-Kawecka presents her research on 3D epigenome remodeling in endocrine-resistant breast cancer. She begins by explaining that about 70% of breast cancers are estrogen receptor-positive and treated with endocrine therapy, but 30% of patients relapse due to resistance. Using cell line models (MCF7 sensitive, TamR and FasR resistant), her group investigates epigenetic changes, particularly DNA methylation and chromatin organization. They performed in situ Hi-C to identify differential enhancer-promoter interactions, finding thousands of changes between sensitive and resistant cells. These interactions are associated with altered ER binding and DNA methylation. They also observed changes in A/B compartments, which correlate with gene expression changes. Key genes like ESR1 and GREB1 are downregulated in resistant cells, linked to loss of interactions and hypermethylation. The findings suggest that 3D genome remodeling is a key mechanism in endocrine resistance. The presentation includes Q&A where she discusses causality, validation in PDX models, and technical aspects of compartment analysis.

153 words

Critical Evaluation

Value of the Information & Strength of the Argument

The value of the information is high, as it presents novel insights into the role of 3D genome organization in endocrine resistance. The argumentation is solid, based on comprehensive multi-omics data integration (Hi-C, ChIP-seq, WGBS, RNA-seq). The speaker clearly explains the hypothesis and systematically tests it, providing evidence for the association between differential interactions, ER binding, and DNA methylation. The use of cell line models is appropriate, and the inclusion of clinical samples, albeit limited, strengthens the relevance. The argumentation is logical and well-supported by data, though the causal relationship is not fully established, which is acknowledged.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is high, with the use of established techniques and appropriate controls. The sources are not explicitly cited in the video, but the methods are standard and the work is likely published. The title accurately reflects the content, focusing on 3D epigenome remodeling. The presentation is well-structured and the conclusions are supported by the data. The lack of explicit citations is a minor weakness, but the methodology is transparent. The adequacy between title and content is perfect.

191 words

Title / Content Match

The title accurately reflects the content, focusing on 3D epigenome remodeling in endocrine-resistant breast cancer.

Quality & Reliability

8/10

The presentation is based on original research using established methods (Hi-C, ChIP-seq, WGBS) and includes validation in clinical samples, though limited by small sample size.

Key Moments

Contribution & Novelties

This presentation provides novel insights into the role of 3D genome organization in endocrine-resistant breast cancer, specifically linking differential enhancer-promoter interactions and A/B compartment changes to altered ER binding and DNA methylation. The integration of multiple epigenomic datasets in resistant cell lines and clinical samples is a significant contribution.

Pour aller plus loin :

87 words

Radar Profile

The radar profile shows high scores across all dimensions, indicating a well-rounded presentation with strong technical depth, reliable information, and substantial content. The balance between quantity and quality of information is excellent, and the technical level is appropriate for an expert audience.

Reliability 8/10